Multi-Omics Integrative Analysis
Multi-Omics Integrative Analysis
Services
Online Inquiry

Multi-Omics Integrative Analysis

Multi-Omics Integration

Uncover cross-level molecular relationships by integrating genomics, transcriptomics, proteomics, and metabolomics into a single, actionable biological model.

  • Integrate genomics, transcriptomics, proteomics, and metabolomics data
  • Normalize batch effects and correlate biomolecular levels across omic layers
  • Apply GO, pathway enrichment, and molecular interaction network analysis
  • Identify candidate biomarkers and causal regulatory relationships
  • Deliver a comprehensive integrated report with customizable visualizations

Why Integrate Multi-Omics Data?

Single-omic analyses often miss the regulatory crosstalk between molecular layers. Our integrative approach reveals how genes, transcripts, proteins, and metabolites coordinate in disease and development.

  • Reduces limitations of individual omic methods for more accurate insights
  • Captures systematic gene–regulatory–metabolic networks
  • Supports biomarker identification for precision medicine and drug target discovery
  • Applicable to plant, animal, biomedical, and environmental research
Comprehensive
Accurate
Systematic
Our Integrated Framework

From Multi-Layer Data to Biological Insight

Our multi-omics pipeline combines data harmonization, cross-omic correlation, and functional interpretation to build a cohesive molecular model of your system.

Core Integration Pipeline

We normalize and correlate data from different omic levels—genomics, transcriptomics, proteomics, metabolomics—using comparative and correlation statistics, then enrich with functional and pathway analyses.

  • Data acquisition and quality control from multiple omic platforms
  • Normalization and batch-effect correction (e.g., ComBat, limma)
  • Cross-omic correlation and co-expression analysis
  • Functional enrichment (GO, KEGG, Reactome) and molecular interaction mapping

Causal & Regulatory Inference

Beyond correlation, we employ network analysis and causal inference methods to identify directionality and regulatory relationships between molecules across omic layers.

  • Construction of gene–protein–metabolite interaction networks
  • Causal inference algorithms to predict upstream regulators
  • Integration with literature databases for mechanistic support
  • Prioritization of key nodes for biomarker or target validation

Rigorous QC

Each dataset undergoes platform-specific quality checks, outlier detection, and cross-omic consistency evaluation to ensure reliable integration.

Statistical Integrity

We apply appropriate multiple-testing corrections (BH, Bonferroni) and use robust methods for batch-effect removal and correlation analysis to minimize false discoveries.

Biological Interpretability

Results are contextualized within known pathways, ontologies, and literature, providing a narrative that connects molecular changes to phenotypic outcomes.

What You Receive

Comprehensive Multi-Omics Outputs

Our final deliverables are designed to be directly actionable, combining data files, interactive visualizations, and a written interpretation report.

Data Deliverables

  • Normalized and batch-corrected multi-omic data matrices
  • Cross-omic correlation matrices and heatmaps
  • Functional enrichment tables (GO, KEGG, Reactome) with statistics
  • Molecular interaction network files (Cytoscape-compatible)
  • Causal inference results and prioritized target lists

Reporting & Support

  • Detailed integrated analysis report with methods and results
  • Customizable visualizations (network plots, volcano plots, chord diagrams)
  • Project-specific consultation calls to review findings
  • Option for follow-up validation experiments (e.g., targeted proteomics)
Service Scope

Project Parameters Customized to Your Study

We scope each project individually based on omic layers, sample size, and research questions. Below are typical parameters that can be tailored.

ParameterTypical Project Scope
Omic Layers IntegratedGenomics, transcriptomics, proteomics, metabolomics, lipidomics, methylation (choose 2–4 per project)
Data Types AcceptedFASTQ, count matrices, normalized abundance tables, raw spectra (project-specific pipeline)
Normalization & Batch CorrectionComBat, limma, quantile normalization, median normalization (method selected per data type)
Correlation MethodsPearson, Spearman, partial correlation, sparse canonical correlation analysis (sCCA)
Functional Enrichment DatabasesGO (BP, MF, CC), KEGG, Reactome, WikiPathways, MSigDB
Molecular Interaction SourcesSTRING, BioGRID, IntAct, KEGG pathways, literature-curated networks
Causal Inference ToolsNestedCohort, ARACNe, GENIE3, Bayesian network inference (selected per project)
Customization OptionsCustom comparisons, alternative pipelines, integrated with existing study metadata
Project Workflow

Five-Step Integrated Analysis Process

Our standardized yet flexible workflow ensures robust integration from raw data to biological interpretation.

Multi-Omic Data Acquisition

Receive raw data (FASTQ, spectra, abundance tables) and experimental metadata. Perform platform-specific quality control and preprocessing (adapter trimming, read alignment, quantification).

Data Normalization & Batch Correction

Apply batch-effect removal (ComBat, limma) and normalize each omic dataset to a comparable scale. Impute missing values using appropriate methods and generate consistent matrices for integration.

Cross-Omic Integration & Correlation

Perform pairwise correlation analyses across omic layers (e.g., transcript–protein, protein–metabolite). Use multivariate methods (sCCA, DIABLO) to identify multi-omic signatures and co-regulation patterns.

Functional & Network Analysis

Conduct GO and pathway enrichment on integrated modules. Construct molecular interaction networks linking genes, proteins, and metabolites. Overlay causal inference results to hypothesize regulatory hierarchies.

Interpretation & Reporting

Compile a comprehensive report including visualizations (network plots, heatmaps, enrichment bar charts), statistical tables, and a narrative summary of key biological findings. Provide supporting data files for further exploration.

Applications

Empowering Diverse Research Fields

Our multi-omics integrative analysis service supports studies across biomedical, agricultural, and environmental domains.

Biomarker Discovery & Disease Mechanism Elucidation

Identify multi-omic signatures for patient stratification and drug target validation. Uncover cross-level regulatory changes in cancer, neurodegenerative, and immune disorders.

  • Integrative analysis of tumor genomic and proteomic landscapes
  • Identification of metabolic pathway rewiring in disease progression
  • Causal inference from germline variants to protein expression

Functional Gene Mining & Trait Improvement

Relate transcripts, proteins, and metabolites to agronomic traits. Support molecular breeding and rare species conservation.

  • Correlate metabolite profiles with yield or stress tolerance
  • Map gene-to-metabolite networks for secondary metabolism
  • Integrate genomic markers with transcriptomic data for marker-assisted selection

Target Identification & Mechanism of Action

Use multi-omics integration to nominate druggable targets and predict drug efficacy or side effects by connecting molecular layers.

  • Integrate chemoproteomics and transcriptomics to identify off-target effects
  • Network-based prioritization of protein targets from genomic and metabolomic data
  • Biomarker panels for patient stratification in clinical trials
Frequently Asked Questions

Common Questions About Multi-Omics Integration

We address key concerns to help you decide whether integrative analysis is right for your project.

  • We integrate any combination of genomics, transcriptomics, proteomics, metabolomics, lipidomics, and epigenomics (e.g., DNA methylation). Data can come from various platforms including next-generation sequencing, mass spectrometry, and microarrays. We work with raw files (FASTQ, spectra) or pre-processed abundance matrices. Specific requirements are scoped during consultation.

  • We apply batch-effect removal algorithms such as ComBat and limma on each omic dataset before integration. When combining data across platforms, we use normalization methods that make the distribution comparable, such as quantile normalization or median scaling. The choice of method depends on data characteristics and is detailed in the analysis plan.

  • Yes. Our service is project-scoped. We can design custom comparisons (e.g., disease vs. control), integrate external metadata (e.g., clinical variables), and focus on particular pathways or molecule types. The analysis plan is discussed and agreed upon before the project starts.

  • You receive normalized data matrices, correlation/network files, enrichment tables, and a detailed report with visualizations and biological interpretation. Raw output files are provided in common formats (CSV, TSV, Cytoscape.sif, RData). All methods and results are documented to ensure reproducibility.

  • Yes. For organisms without well-annotated genomes or pathways, we use homology-based functional annotation (e.g., GO mapping via orthologs) and context-specific network inference. We also work with custom reference databases provided by the client. Feasibility is evaluated during the initial scope discussion.

Scientific Literature

References

  1. Li J, Wang F, Li Z, et al. Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis. Journal of translational medicine. 2024;22(1):302. View on PubMed
  2. Li S, Lin Y, Gao X, et al. Integrative multi-omics analysis reveals a novel subtype of hepatocellular carcinoma with biological and clinical relevance. Frontiers in immunology. 2024;15:1517312. View on PubMed
  3. Cortez Cardoso Penha R, Sexton Oates A, Senkin S, et al. Understanding the biological processes of kidney carcinogenesis: an integrative multi-omics approach. Molecular systems biology. 2024;20(12):1282-1302. View on PubMed
  4. Jiang H, Gao B, Meng Z, et al. Integrative multi-omics analysis reveals the role of tumor-associated endothelial cells and their signature in prognosis of intrahepatic cholangiocarcinoma. Journal of translational medicine. 2024;22(1):948. View on PubMed
  5. Xu M, Sun Z, Wang D, et al. Integrative multi-omics analysis decodes HOXC9-driven malignant transformation and metastasis in OSCC. iScience. 2025;28(9):112919. View on PubMed
  6. Sun YV, Hu YJ. Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases. Advances in genetics. 2016;93:147-90. View on PubMed

Please kindly note that our products and services are for research use only.